Over the last decade, Poland has seen the rise of its biotech industry. While the country’s pharmaceutical industry has traditionally focused on developing generics, many of these companies have started moving towards developing biologics. Meanwhile, biotech startups in Poland are working on developing new technologies, with a strong focus on treatments for cancer and autoimmune disease.
As the country sees success stories in its biotech sector, more and more academics and entrepreneurs have been encouraged to take the leap and start a business in Poland’s flourishing biotech industry. Here, we have selected eight companies at the forefront of Poland’s promising biotech industry.
NanoVelos:
A spin-out of the Warsaw University of Technology in Poland, biotech
company NanoVelos is developing nanoparticles to deliver cancer drugs.
The nanoparticles, made of dextran molecules, are designed to only
release the drugs they carry when inside a cancer cell, thus increasing
the drug’s efficacy while reducing its potential side effects. Dextran
is a hydrophilic and biocompatible complex derived from glucose, useful
in medical and pharmaceutical applications. Its solubility in water and
biocompatibility make it ideal for various applications such as drug
delivery. The technology is still in preclinical development, with some
of the projects focusing on enhancing generic forms of existing drugs.
The
company’s technology focuses on poly(lactide-co-glycolide) (PLGA) and
acrylic acid-based nanoparticles that protect drugs from enzymatic
degradation and target specific endogenous ligands. This delivery system
is particularly advantageous for cancer therapies, providing targeted
treatment and reducing damage to healthy tissues.
Read the whole article on the LABIOTECH website.
